Gender differences in severity of sickle cell diseases in non-smokers

Pakistan Journal of Medical Sciences

Volumn 29, Issue 4, 2013, Pages 1050-1054

  Helvaci, Mehmet Rami ^a   Ayyildiz, Orhan ^b   Gundogdu, Mehmet ^c  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

^c ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Gender differences; Non smokers; Sickle cell diseases

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUBBING FINGERS; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PULMONARY HYPERTENSION; SEX DIFFERENCE; SEX RATIO; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; SMOKING;

EID: 84879835146     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.294.3697     Document Type: Article

References (21)

1. Helvaci MR, Aydin LY, Aydin Y. Digital clubbing may be an indicator of systemic atherosclerosis even at microvascular level. Health MED. 2012;6:3977-3981.
2. Helvaci MR, Aydin Y, Gundogdu M. Smoking induced atherosclerosis in cancers. Health MED. 2012;6:3744-3749.
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428.
4. Helvaci MR, Kaya H, Gundogdu M. Association of increased triglyceride levels in metabolic syndrome with coronary artery disease. Pak J Med Sci. 2010;26:667-672.
5. Helvaci MR, Kaya H, Seyhanli M, Yalcin A. White coat hypertension in definition of metabolic syndrome. Int Heart J. 2008;49:449-457.
6. Helvaci MR, Kaya H, Seyhanli M, Cosar E. White coat hypertension is associated with a greater all-cause mortality. J Health Sci. 2007;53:156-160.
7. Helvaci MR, Erden ES, Aydin LY. Atherosclerotic background of chronic obstructive pulmonary disease in sickle cell patients. Health MED. 2013;7:484-488.
8. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2010. Global initiative for chronic obstructive lung disease (GOLD).
9. Fisher MR, Forfa PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179:615-621.
10. Schamroth L. Personal experience. S Afr Med J. 1976;50:297-300.
11. Vandemergel X, Renneboog B. Prevalence, aetiologies and significance of clubbing in a department of general internal medicine. Eur J Intern Med. 2008;19:325-329.
12. Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342:83-89.
13. Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics 1989;84:500-508.
14. Helvaci MR, Aydin Y, Ayyildiz O. Hydroxyurea may prolong survival of sickle cell patients by decreasing frequency of painful crises. HealthMED (in press).
15. Cole TB, Sprinkle RH, Smith SJ, Buchanan GR. Intravenous narcotic therapy for children with severe sickle cell pain crisis. Am J Dis Child. 1986;140:1255-1259.
16. Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992;120:360-366.
17. Helvaci MR, Kaya H. Effect of sickle cell diseases on height and weight. Pak J Med Sci. 2011;27:361-364.
18. Helvaci MR, Kaya H, Duru M, Yalcin A. What is the relationship between white coat hypertension and dyslipidemia? Int Heart J. 2008;49:87-93.
19. Helvaci MR, Kaya H, Sevinc A, Camci C. Body weight and white coat hypertension. Pak J Med Sci. 2009;25:6:916-921.
20. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
21. Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD. Healthy life expectancy in 191 countries, 1999. Lancet. 2001;357:1685-1691.